Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei-Fei Zhou

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Medical Oncology (Northwood, London, England)|July 24, 2010
Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cellsFei-fei Zhou, Min Yan, Gui-fang Guo, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 5, 2009
[Efficacy of cetuximab combined with chemotherapy on advanced colorectal cancer: a report of 53 cases]Gui-Fang Guo, Liang-Ping Xia, Bei Zhang, et al.
Medical Oncology (Northwood, London, England)|October 23, 2010
Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 casesLiang-Ping Xia, Hui-Juan Qiu, Xu-Xian Chen, et al.
Cancer Biology & Medicine|May 22, 2013
Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung CancerFang Wang, Gui-Fang Guo, Hui-Juan Qiu, et al.
Medical Oncology (Northwood, London, England)|November 17, 2010
Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosisGui Fang Guo, Yu Chen Cai, Bei Zhang, et al.
Quantitative Imaging in Medicine and Surgery|May 3, 2021
The clinical value of three-dimensional measurement in the diagnosis of thoracic myelopathy caused by ossification of the ligamentum flavumChen Yan, Hao-Yuan Tan, Cheng-Long Ji, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|September 5, 2009
[Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases]Liang-Ping Xia, Bei Zhang, Mao-Zhen Liu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Medical Oncology (Northwood, London, England)|July 24, 2010
Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cellsFei-fei Zhou, Min Yan, Gui-fang Guo, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 5, 2009
[Efficacy of cetuximab combined with chemotherapy on advanced colorectal cancer: a report of 53 cases]Gui-Fang Guo, Liang-Ping Xia, Bei Zhang, et al.
Medical Oncology (Northwood, London, England)|October 23, 2010
Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 casesLiang-Ping Xia, Hui-Juan Qiu, Xu-Xian Chen, et al.
Cancer Biology & Medicine|May 22, 2013
Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung CancerFang Wang, Gui-Fang Guo, Hui-Juan Qiu, et al.
Medical Oncology (Northwood, London, England)|November 17, 2010
Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosisGui Fang Guo, Yu Chen Cai, Bei Zhang, et al.
Quantitative Imaging in Medicine and Surgery|May 3, 2021
The clinical value of three-dimensional measurement in the diagnosis of thoracic myelopathy caused by ossification of the ligamentum flavumChen Yan, Hao-Yuan Tan, Cheng-Long Ji, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|September 5, 2009
[Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases]Liang-Ping Xia, Bei Zhang, Mao-Zhen Liu, et al.
Pageof 3